Orchard raises $150 mln to expand after GSK gene therapy deal
12 Aug Orchard raises $150 mln to expand after GSK gene therapy deal
Posted at 12:08h
in
News
by KMFSLLP
Anglo-American biotech company
Orchard Therapeutics has raised a further $150 million to fund
its work in gene therapy, building on earlier fundraisings worth
more than $140 million.
Sorry, the comment form is closed at this time.